A method transfer is not complete because two laboratories obtain similar main-peak areas once. The receiving laboratory must demonstrate that the procedure remains fit for its intended analytical purpose.
Define the analytical target before the protocol
Following the lifecycle logic of ICH Q2(R2) and Q14, specify the attribute, reportable range and performance required. An identity-supporting chromatographic procedure, a related-substances method and a quantitative assay do not have the same validation or transfer priorities.
Lock down the details that actually move retention and selectivity
For peptide RP-HPLC, column chemistry and lot, gradient dwell volume, mobile-phase preparation, temperature, sample solvent, injection load, detector settings and integration can alter the profile. Record instrument configuration and translate gradients when dwell volumes differ rather than copying a timetable blindly.
Design acceptance criteria prospectively
Use representative samples, a qualified reference or system-suitability mixture, predefined injections and criteria for precision, resolution, tailing, retention and sensitivity where relevant. Include at least one challenging or impurity-containing sample. Investigate systematic differences; do not average them away.
Decision Table
| Transfer element | Protocol question | Typical evidence |
|---|---|---|
| Purpose | Which quality attribute is measured? | ATP/intended use |
| Selectivity | Are critical pairs still resolved? | Spiked or stressed sample |
| Precision | Is repeatability adequate? | Replicate preparations/injections |
| Instrument equivalence | Are dwell volume and detector comparable? | Configuration and gradient translation |
| Data processing | Are integration rules controlled? | Approved processing method |
What Belongs in the Procurement File
The purchasing specification should name the material form, intended analytical use, methods, acceptance criteria, sample and lot identifiers, packaging, storage and change-notification requirements. The receiving record should reconcile those requirements with the vial, COA, raw or controlled analytical output and shipping history. For the broader framework, consult the 2026 wholesale buyer’s guide, the HPLC review and the mass-spectrometry review.
Frequently Asked Questions
Is six replicate injections a complete method transfer?
Usually not. Injection precision alone does not demonstrate sample preparation, selectivity or inter-laboratory equivalence.
Can a different HPLC column be substituted?
Only after demonstrating that the method remains fit for purpose; nominally similar phases can differ in selectivity.
Technical Reference
Primary or authoritative reference used for this article. Its findings should be applied only within the material, formulation and method conditions described.